Aborto Legal, Aborto Inducido, Misoprostol, Redes Comunitarias, Feminismo, Argentina
La disponibilidad de medicamentos para producir un aborto, sobre todo en contextos de acceso restringido, transformó las prácticas y permitió que las propias mujeres y/o sus organizaciones comunitarias ayuden a otras mujeres a abortar, interactuando o no con el sistema de salud. Este estudio recupera la experiencia de una organización feminista de la comunidad que, desde la provincia de Neuquén, se extiende a todo el país, generando una red de cuidados comunitarios. Se realizó un estudio exploratorio descriptivo, con enfoque cualitativo con el propósito de analizar las experiencias de las mujeres que facilitan el acceso al aborto permitido en Argentina. A través de entrevistas en profundidad a tres líderes de la colectiva feminista La Revuelta y de entrevistas semiestructuradas a 33 integrantes de las grupas socorristas, realizadas entre noviembre de 2019 y diciembre de 2020, describimos su historia y los procesos de trabajo y crecimiento; exploramos sus motivaciones y sentimientos y caracterizamos las interacciones de dichas organizaciones con los sistemas de salud público y privado. Los resultados de este trabajo coinciden con la conversación y la producción bibliográfica internacional acerca de estas organizaciones y sus particularidades y con la necesidad de incorporar estos cuidados a los sistemas de salud institucionales.
1. Organización Mundial de la Salud. Aborto sin riesgos [Internet]. 2012 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/bttcumnd.
2. Ganatra B, Gerdts C, Rossier C, Johnson BR, Tunçalp Ö, Assifi A, et al. Global, regional, and subregional classification of abortions by safety, 2010–14: estimates from a Bayesian hierarchical model. Lancet. 2017;390(10110):2372-2381. DOI: https://doi.org/10.1016/S0140-6736(17)31794-4
3. Calvert C, Owolabi OO, Yeung F, Pittrof R, Ganatra B, Tunçalp Ö, et al. The magnitude and severity of abortionrelated morbidity in settings with limited access to abortion services: A systematic review and meta-regression. BMJ Global Health. 2018;3:e000692. DOI: https://doi.org/10.1136/bmjgh-2017-000692
4. Bearak J, Popinchalk A, Ganatra B, Moller AB, Tunçalp Ö, Beavin C, et al. Unintended pregnancy and abortion by income, region, and the legal status of abortion: estimates from a comprehensive model for 1990–2019. Lancet Global Health. 2020;8(9):e1152-e1161. DOI: https://doi.org/10.1016/S2214-109X(20)30315-6
5. Starrs AM, Ezeh AC, Barker G, Basu A, Bertrand JT, Blum R, et al. Accelerate progress—sexual and reproductive health and rights for all: report of the Guttmacher–Lancet Commission. The Lancet. 2018;391(10140):2642-2692. DOI: https://doi.org/10.1016/S0140-6736(18)30293-9
6. Anzorena CC. El derecho al aborto legal, seguro y gratuito en Argentina: obstáculos y desafíos de la política en acto a 18 meses de su implementación (2021-2022). Salud Colectiva. 2023;19:e4613. DOI: https://doi.org/10.18294/sc.2023.4613
7. Tiseyra MV, Vila Ortiz M, Romero M, Abalos E, Ramos S. Barreras de acceso al aborto legal en el sistema público de salud de dos jurisdicciones de Argentina: Rosario y Ciudad Autónoma de Buenos Aires, 2019-2020. Salud Colectiva. 2022;18:e4059. DOI: https://doi.org/10.18294/sc.2022.4059
8. Ramos S, Romero M, Aizenberg L, Ramos S, Romero M. Women’s experiences with the use of medical abortion in a legally restricted context: the case of Argentina. Reproductive Health Matters. 2015;22(Supl 1):4-15. DOI: https://doi.org/10.1016/S0968-8080(14)43786-8
9. Zamberlin N, Romero M, Ramos S. Latin American women’s experiences with medical abortion in settings where abortion is legally restricted. Reproductive Health. 2012;9:34. DOI: https://doi.org/10.1186/1742-4755-9-34
10. Robson SC, Kelly T, Howel D, Deverill M, Hewison J, Lie MLS, et al. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks’ gestation (TOPS). Health Technology Assessment. 2009;13(53):1–124. DOI: https://doi.org/10.3310/hta13530
11. Winikoff B, Dzuba IG, Chong E, Goldberg AB, Steve Lichtenberg E, Ball C, et al. Extending outpatient medical abortion services through 70 days of gestational age. Obstetrics and Gynecology. 2012;120(5):1070-1076. DOI: https://doi.org/10.1097/AOG.0b013e31826c315f
12. Zurbriggen R, Keefe-Oates B, Gerdts C. Accompaniment of second-trimester abortions: the model of the feminist Socorrista network of Argentina. Contraception. 2018;97(2):108-115. DOI: https://doi.org/10.1016/j.contraception.2017.07.170
13. Berro Pizzarossa L, Nandagiri R. Self-managed abortion: a constellation of actors, a cacophony of laws? Sexual and Reproductive Health Matters. 2021;29(1):1899764. DOI: https://doi.org/10.1080/26410397.2021.1899764
14. Argentina. Decreto 297/2020 Aislamiento Social Preventivo y Obligatorio [Internet]. 2020 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/7pn2tx5m.
15. Lesbianas y Feministas por la Descriminalización del Aborto. Todo lo que querés saber sobre cómo hacerse un aborto con pastillas. Buenos Aires: Editorial El Colectivo; 2010.
16. Socorristas en Red. Sistematización de acompañamientos a abortar. [Internet]. 2022 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/2n229a68.
17. World Health Organization. Abortion care guideline [Internet]. 2022 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/ysykufkm.
18. Gambir K, Kim C, Ka N, Ganatra B, Td N, Gambir K, et al. Self-administered versus provider-administered medical abortion. The Cochrane database of systematic reviews. 2020;3(3):CD013181. DOI: https://doi.org/10.1002/14651858.CD013181.pub2
19. Hyland P, Raymond EG, Chong E. A direct-to-patient telemedicine abortion service in Australia: Retrospective analysis of the first 18 months. Australian & New Zealand Journal of Obstetrics & Gynaecology. 2018;58(3):335-340. DOI: https://doi.org/10.1111/ajo.12800
20. Hyman A, Blanchard K, Coeytaux F, Grossman D, Teixeira A. Misoprostol in women’s hands: A harm reduction strategy for unsafe abortion. Contraception. 2013;87(2):128-130. DOI: https://doi.org/10.1016/j.contraception.2012.10.020
21. Kero A, Wulff M, Lalos A. Home abortion implies radical changes for women. European Journal of Contraception and Reproductive Health Care. 2009;14(5):324-333. DOI: https://doi.org/10.3109/13625180903128609
22. Song LP, Tang SY, Li CL, Zhou LJGYK, Mo XT. Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol. Journal of Obstetrics and Gynaecology Research. 2018;44(9):1705-1711. DOI: https://doi.org/10.1111/jog.13716
23. Tan YL, Singh K, Tan KH, Gosavi A, Koh D, Abbas D, et al. Acceptability and feasibility of outpatient medical abortion with mifepristone and misoprostol up to 70 days gestation in Singapore. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2018;229:144-147. 10.1016/j.ejogrb.2018.08.014. DOI: https://doi.org/10.1016/j.ejogrb.2018.08.014
24. Braine N. Autonomous health movements: Criminalization, de-medicalization, and community-based direct action. Health and Human Rights. 2020;22(2):85-97.
25. Jelinska K, Yanow S. Putting abortion pills into women’s hands: realizing the full potential of medical abortion. Contraception. 2018;97(2):86-89. DOI: https://doi.org/10.1016/j.contraception.2017.05.019
26. Gerdts C, Jayaweera RT, Kristianingrum IA, Khan Z, Hudaya I. Effect of a smartphone intervention on self-managed medication abortion experiences among safe-abortion hotline clients in Indonesia: A randomized controlled trial. International Journal of Gynaecology and Obstetrics. 2020;149(1):48–55. DOI: https://doi.org/10.1002/ijgo.13086
27. Harries J, Daskilewicz K, Bessenaar T, Gerdts C. Understanding abortion seeking care outside of formal health care settings in Cape Town, South Africa: a qualitative study. Reproductive Health. 2021;18:190. DOI: https://doi.org/10.1186/s12978-021-01243-3
28. Organización Mundial de la Salud. Directrices unificadas sobre intervenciones de autoasistencia sanitaria [Ïnternet]. 2019 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/bdd98ja2.
29. Chemlal S, Russo G. Why do they take the risk? A systematic review of the qualitative literature on informal sector abortions in settings where abortion is legal. BMC Womens Health. 2019;19(1):55. DOI: https://doi.org/10.1186/s12905-019-0751-0
30. Baum SE, Ramirez AM, Larrea S, Filippa S, Egwuatu I, Wydrzynska J, et al. “It’s not a seven-headed beast”: abortion experience among women that received support from helplines for medication abortion in restrictive settings. Health Care for Women International. 2020;41(10):1128-1146. DOI: https://doi.org/10.1080/07399332.2020.1823981
31. Aiken ARA, Lohr PA, Lord J, Ghosh N, Starling J. Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study. BJOG. 2021;128(9):1464-1474. DOI: https://doi.org/10.1111/1471-0528.16668
32. Grossman D, Baum SE, Andjelic D, Tatum C, Torres G, Fuentes L, et al. A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up : A cohort study. Plos One. 2018;13(1):e0189195. DOI: https://doi.org/10.1371/journal.pone.0189195
33. Moseson H, Keefe-Oates B, Jayaweera RT, Filippa S, Motana R, Bercu C, et al. Studying Accompaniment model Feasibility and Effectiveness (SAFE) Study: Study protocol for a prospective observational cohort study of the effectiveness of self-managed medication abortion. BMJ Open. 2020;10:e036800. DOI: https://doi.org/10.1136/bmjopen-2020-036800
34. Moseson H, Herold S, Filippa S, Barr-Walker J, Baum SE, Gerdts C. Self-managed abortion: A systematic scoping review. Best Practice & Research, Clinical Obstetrics & Gynaecology. 2020;63:87-110. DOI: https://doi.org/10.1016/j.bpobgyn.2019.08.002
35. Moseson H, Jayaweera R, Egwuatu I, Grosso B, Kristianingrum IA, Nmezi S, et al. Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls. Lancet Global Health. 2022;10(1):e105-e113. DOI: https://doi.org/10.1016/S2214-109X(21)00461-7
36. Atienzo EE, Zurbriggen R, Gerdts C, Zambrano D, Keefe-oates B, Wollum A. Characterizing two models for abortion. Revista de Saúde Pública. 2023;57:36. DOI: https://doi.org/10.11606/s1518-8787.2023057004993
37. Yanow S, Pizzarossa LB, Jelinska K. Self-managed abortion: Exploring synergies between institutional medical systems and autonomous health movements. Contraception. 2021;104(3):219-221. DOI: https://doi.org/10.1016/j.contraception.2021.06.006
38. Pizzarossa LB, Skuster P. Toward human rights and evidence-based legal frameworks for (self-managed) abortion: A review of the last decade of legal reform. Health and Human Rights. 2021;23(1):199–212.
39. Socorristas en Red. Sistematizacion de acompañamientos a abortar: Realizados en el año 2019 por Socorristas en Red (feministas que abortamos) [Internet]. 2020 [citado 10 oct 2023]. Disponible en: https://tinyurl.com/3r5jjcfh.
40. Burton J. Você precisa abortar? Onde quer que você esteja, nós te acompanhamos: pandemia e acompanhamento de abortos em Neuquén, Argentina, durante 2020. Cadernos Ibero-Americanos de Direito Sanitário. 2023:12(4). DOI: https://doi.org/10.17566/ciads.v12i4.1200
41. Gudiño Bessone P, Drovetta RI, Rúa A. Ações para o aborto seguro durante a pandemia: o caso das práticas de duas organizações na Argentina. Ações para o aborto seguro durante a pandemia: o caso das práticas de duas organizações na Argentina. 2023;12(4). DOI: https://doi.org/10.17566/ciads.v12i4.1199
ISSN 1669-2381 (versión impresa) | ISSN 1851-8265 (versión electrónica) | 2250-5334 (english edition)
Editora Responsable: Viviana Martinovich
Propietario: Universidad Nacional de Lanús
Rector: Daniel Rodriguez Bozzani
29 de Septiembre 3901, Remedios de Escalada, Lanús (B1826GLC), Provincia de Buenos Aires, Argentina